טוען...
Drug Company–Sponsored Patient Assistance Programs: A Viable Safety Net?
The benefits of drug company–sponsored PAPs remain unclear. Drug company–sponsored patient assistance programs (PAPs) provide access to brand-name medications at little or no cost and have been advocated as a safety net for inadequately insured patients. Yet little is known about these programs. We...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2873618/ https://ncbi.nlm.nih.gov/pubmed/19414893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1377/hlthaff.28.3.827 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|